BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

564 related articles for article (PubMed ID: 34780969)

  • 1. Long-term immunologic effects of SARS-CoV-2 infection: leveraging translational research methodology to address emerging questions.
    Peluso MJ; Donatelli J; Henrich TJ
    Transl Res; 2022 Mar; 241():1-12. PubMed ID: 34780969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The immunology and immunopathology of COVID-19.
    Merad M; Blish CA; Sallusto F; Iwasaki A
    Science; 2022 Mar; 375(6585):1122-1127. PubMed ID: 35271343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammation, immunity, and antigen persistence in post-acute sequelae of SARS-CoV-2 infectionImmunity and inflammaion in post-acute sequelae of SARS-CoV-2 infection.
    Newell KL; Waickman AT
    Curr Opin Immunol; 2022 Aug; 77():102228. PubMed ID: 35724449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term complications of COVID-19.
    Desai AD; Lavelle M; Boursiquot BC; Wan EY
    Am J Physiol Cell Physiol; 2022 Jan; 322(1):C1-C11. PubMed ID: 34817268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic Changes of the Blood Chemistry in Syrian Hamsters Post-Acute COVID-19.
    Hsu CJ; Lin WC; Chou YC; Yang CM; Wu HL; Cheng YH; Liu PC; Chang JY; Chen HY; Sun JR
    Microbiol Spectr; 2022 Feb; 10(1):e0236221. PubMed ID: 35196799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms.
    Peluso MJ; Deitchman AN; Torres L; Iyer NS; Munter SE; Nixon CC; Donatelli J; Thanh C; Takahashi S; Hakim J; Turcios K; Janson O; Hoh R; Tai V; Hernandez Y; Fehrman EA; Spinelli MA; Gandhi M; Trinh L; Wrin T; Petropoulos CJ; Aweeka FT; Rodriguez-Barraquer I; Kelly JD; Martin JN; Deeks SG; Greenhouse B; Rutishauser RL; Henrich TJ
    Cell Rep; 2021 Aug; 36(6):109518. PubMed ID: 34358460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central nervous system outcomes of COVID-19.
    Doyle MF
    Transl Res; 2022 Mar; 241():41-51. PubMed ID: 34601116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterizing the COVID-19 Illness Experience to Inform the Study of Post-acute Sequelae and Recovery.
    Santiago-Rodriguez EI; Maiorana A; Peluso MJ; Hoh R; Tai V; Fehrman EA; Hernandez Y; Torres L; Spinelli MA; Gandhi M; Kelly JD; Martin JN; Henrich TJ; Deeks SG; Sauceda JA
    Int J Behav Med; 2022 Oct; 29(5):610-623. PubMed ID: 34918211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Return-to-work, disabilities and occupational health in the age of COVID-19.
    Godeau D; Petit A; Richard I; Roquelaure Y; Descatha A
    Scand J Work Environ Health; 2021 Jul; 47(5):408-409. PubMed ID: 34003294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-Term Symptoms Among Adults Tested for SARS-CoV-2 - United States, January 2020-April 2021.
    Wanga V; Chevinsky JR; Dimitrov LV; Gerdes ME; Whitfield GP; Bonacci RA; Nji MAM; Hernandez-Romieu AC; Rogers-Brown JS; McLeod T; Rushmore J; Lutfy C; Bushman D; Koumans E; Saydah S; Goodman AB; Coleman King SM; Jackson BR; Cope JR
    MMWR Morb Mortal Wkly Rep; 2021 Sep; 70(36):1235-1241. PubMed ID: 34499626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-lateral damage: cardiovascular manifestations of SARS-CoV-2 infection.
    Al-Kindi S; Zidar DA
    Transl Res; 2022 Mar; 241():25-40. PubMed ID: 34780967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Neurological Manifestations of Post-Acute Sequelae of SARS-CoV-2 infection.
    Moghimi N; Di Napoli M; Biller J; Siegler JE; Shekhar R; McCullough LD; Harkins MS; Hong E; Alaouieh DA; Mansueto G; Divani AA
    Curr Neurol Neurosci Rep; 2021 Jun; 21(9):44. PubMed ID: 34181102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The immunology of asymptomatic SARS-CoV-2 infection: what are the key questions?
    Boyton RJ; Altmann DM
    Nat Rev Immunol; 2021 Dec; 21(12):762-768. PubMed ID: 34667307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Six-month sequelae of post-vaccination SARS-CoV-2 infection: A retrospective cohort study of 10,024 breakthrough infections.
    Taquet M; Dercon Q; Harrison PJ
    Brain Behav Immun; 2022 Jul; 103():154-162. PubMed ID: 35447302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.
    Chaudhary JK; Yadav R; Chaudhary PK; Maurya A; Kant N; Rugaie OA; Haokip HR; Yadav D; Roshan R; Prasad R; Chatrath A; Singh D; Jain N; Dhamija P
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-acute COVID-19 syndrome after reinfection and vaccine breakthrough by the SARS-CoV-2 Gamma variant in Brazil.
    Penetra SLS; da Silva MFB; Resende P; Pina-Costa A; Santos HFP; Guaraldo L; Calvet GA; Ogrzewalska M; Arantes I; Zukeram K; de Araújo MF; Lima ABM; Lopes RS; Lira-Silva LR; Moraes IV; Wakimoto MD; Fuller TL; Gabaglia CR; Espíndola OM; Bonaldo MC; Daniel-Ribeiro CT; Whitworth J; Smith C; Nielsen-Saines K; Pauvolid-Correa A; Siqueira MM; Brasil P
    Int J Infect Dis; 2022 Jan; 114():58-61. PubMed ID: 34757006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive characterization of the antibody responses to SARS-CoV-2 Spike protein finds additional vaccine-induced epitopes beyond those for mild infection.
    Garrett ME; Galloway JG; Wolf C; Logue JK; Franko N; Chu HY; Matsen FA; Overbaugh JM
    Elife; 2022 Jan; 11():. PubMed ID: 35072628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leveraging South African HIV research to define SARS-CoV-2 immunity triggered by sequential variants of concern.
    Bhiman JN; Moore PL
    Immunol Rev; 2022 Sep; 310(1):61-75. PubMed ID: 35599324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term perturbation of the peripheral immune system months after SARS-CoV-2 infection.
    Ryan FJ; Hope CM; Masavuli MG; Lynn MA; Mekonnen ZA; Yeow AEL; Garcia-Valtanen P; Al-Delfi Z; Gummow J; Ferguson C; O'Connor S; Reddi BAJ; Hissaria P; Shaw D; Kok-Lim C; Gleadle JM; Beard MR; Barry SC; Grubor-Bauk B; Lynn DJ
    BMC Med; 2022 Jan; 20(1):26. PubMed ID: 35027067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-Level Immune Support by Vitamins C and D during the SARS-CoV-2 Pandemic.
    Carr AC; Gombart AF
    Nutrients; 2022 Feb; 14(3):. PubMed ID: 35277048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.